Angiotensin-(1–7) Mas-receptor deficiency decreases peroxisome proliferator-activated receptor gamma expression in adipocytes

Alenina, 2008, Genetically altered animal models for Mas and angiotensin-(1–7), Exp Physiol, 93, 528, 10.1113/expphysiol.2007.040345 Benson, 2004, Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity, Hypertension, 43, 993, 10.1161/01.HYP.0000123072.34629.57 Benter, 2007, Angiotensin-(1–7) prevents diabetes-induced cardiovascular dysfunction, Am J Physiol Heart Circ Physiol, 292, H666, 10.1152/ajpheart.00372.2006 Bogacka, 2004, The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo, Diabetes Care, 27, 1660, 10.2337/diacare.27.7.1660 Boustany, 2004, Activation of the systemic and adipose renin–angiotensin system in rats with diet-induced obesity and hypertension, Am J Physiol Regul Integr Comp Physiol, 287, R943, 10.1152/ajpregu.00265.2004 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 Crackower, 2002, Angiotensin-converting enzyme 2 is an essential regulator of heart function, Nature, 417, 822, 10.1038/nature00786 DeFronzo, 2010, Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009, Diabetologia, 53, 1270, 10.1007/s00125-010-1684-1 Dhaunsi, 2010, Angiotensin-(1–7) prevents diabetes-induced attenuation in PPAR-gamma and catalase activities, Eur J Pharmacol, 638, 108, 10.1016/j.ejphar.2010.04.030 Dias-Peixoto, 2008, Molecular mechanisms involved in the angiotensin-(1–7)/Mas signaling pathway in cardiomyocytes, Hypertension, 52, 542, 10.1161/HYPERTENSIONAHA.108.114280 Ferreira, 2008, Fenofibrate prevents orotic acid-induced hepatic steatosis in rats, Life Sci, 82, 876, 10.1016/j.lfs.2008.02.003 Fraga-Silva, 2008, The antithrombotic effect of angiotensin-(1–7) involves Mas-mediated NO release from platelets, Mol Med, 14, 28, 10.2119/2007-00073.Fraga-Silva Giacchetti, 2005, The renin–angiotensin–aldosterone system, glucose metabolism and diabetes, Trends Endocrinol Metab, 16, 120, 10.1016/j.tem.2005.02.003 Giani, 2009, Chronic infusion of angiotensin-(1–7) improves insulin resistance and hypertension induced by a high-fructose diet in rats, Am J Physiol Endocrinol Metab, 296, E262, 10.1152/ajpendo.90678.2008 Iwai, 2011, Irbesartan increased PPARgamma activity in vivo in white adipose tissue of atherosclerotic mice and improved adipose tissue dysfunction, Biochem Biophys Res Commun, 406, 123, 10.1016/j.bbrc.2011.02.007 Kersten, 2000, Roles of PPARs in health and disease, Nature, 405, 421, 10.1038/35013000 Kim, 2007, Obesity-associated improvements in metabolic profile through expansion of adipose tissue, J Clin Invest, 117, 2621, 10.1172/JCI31021 Kuan, 2011, Identifying the regulatory element for human angiotensin-converting enzyme 2 (ACE2) expression in human cardiofibroblasts, Peptides, 32, 1832, 10.1016/j.peptides.2011.08.009 Lee, 2009, Getting the message across: mechanisms of physiological cross talk by adipose tissue, Am J Physiol Endocrinol Metab, 296, E1210, 10.1152/ajpendo.00015.2009 Nguyen Dinh Cat, 2011, A new look at the renin–angiotensin system-focusing on the vascular system, Peptides, 32, 2141, 10.1016/j.peptides.2011.09.010 Pinheiro, 2009, Genetic deletion of the angiotensin-(1–7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria, Kidney Int, 75, 1184, 10.1038/ki.2009.61 Rodbell, 1964, Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis, J Biol Chem, 239, 375, 10.1016/S0021-9258(18)51687-2 Santos, 2003, Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas, Proc Natl Acad Sci U S A, 100, 8258, 10.1073/pnas.1432869100 Santos, 2010, Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1–7), Arterioscler Thromb Vasc Biol, 30, 953, 10.1161/ATVBAHA.109.200493 Santos, 2008, Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism, Diabetes, 57, 340, 10.2337/db07-0953 Sharma, 2007, Review: peroxisome proliferator-activated receptor gamma and adipose tissue – understanding obesity-related changes in regulation of lipid and glucose metabolism, J Clin Endocrinol Metab, 92, 386, 10.1210/jc.2006-1268 Takai, 2011, Irbesartan prevents metabolic syndrome in rats via activation of peroxisome proliferator-activated receptor gamma, J. Pharmacol. Sci., 116, 309, 10.1254/jphs.11053FP Yu, 2002, Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle, J Biol Chem, 277, 50230, 10.1074/jbc.M200958200